Hawaii SB969 mandates coverage for biomarker testing in insurance policies and health plans starting January 1, 2026.
Hawaii SB969 requires insurance policies and health plans to cover biomarker testing for diagnosis, treatment, management, or monitoring of diseases or conditions, starting January 1, 2026. Insurers and mutual benefit societies must inform policyholders and subscribers about this coverage by December 31, 2026. The bill defines "biomarker" and "biomarker testing" and specifies that coverage should minimize disruptions in care. It also mandates that insurers and mutual benefit societies provide a process for requesting exceptions to coverage restrictions.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.